Ketalux - Ketamine Therapy EducationKetalux - Mental Wellness Authority
Research Library

Long-Term Outcomes in Ketamine Therapy

Long-term outcome data is growing but still incomplete.

Written by: Ira ZootMedically reviewed by: Ketalux Clinical Review PanelLast updated: June 6, 2026Evidence: Multiyear maintenance studies; clinic registries
Quick answer
What do we know about long-term outcomes?
Studies of 1–3 years of maintenance ketamine generally show sustained benefit for responders, with no clear cumulative safety signals at therapeutic doses. Longer-term data (5+ years) remain limited, and clinical practice continues to evolve.

What the data suggest

  • Responders to induction often maintain benefit on individualized maintenance.
  • Pairing with therapy and integration extends durability.
  • A subset experiences sustained remission with reduced or paused maintenance.

Open questions

  • 5+ year cognitive outcomes
  • Optimal maintenance intervals
  • Predictors of long-term remission vs maintenance-dependence

Related reading

Educational content only. Not medical advice. Discuss any treatment decisions with a qualified clinician.

About the author
Ira Zoot

Independent publisher and editor of Ketalux, based in Chicago, Illinois. Ira commissions, edits, and reviews every article on the site and believes ketamine therapy — used responsibly — offers real hope for people living with depression, anxiety, PTSD, and chronic pain. Contact: ira@idigits.com.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.